Tech Company Financing Transactions
Neucore Bio Funding Round
Neucore Bio secured a $350 thousand financing round on 9/2/2025. Backers included National Institutes of Health.
Transaction Overview
Company Name
Announced On
9/2/2025
Transaction Type
Debt
Amount
$350,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1275 Kinnear Road
Columbus, OH 43212
USA
Columbus, OH 43212
USA
Phone
Undisclosed
Website
Email Address
Overview
Neucore Bio, Inc., is an early-stage biotechnology company advancing nonviral, engineered exosomes to power the next generation of genetic medicine and aesthetic dermatology solutions. The company's proprietary platform harnesses the innate programmability of fibroblasts and the natural intercellular signaling of exosomes to deliver nucleic acid therapeutics for disease modification and skin rejuvenation - unlocking new era of performance-driven genetic medicine and functional skincare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Natalia Higuita-Castro
Browse more venture capital transactions:
Prev: 9/2/2025: iEduGPT venture capital transaction
Next: 9/2/2025: Lumentum venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs